betadex and Depressive-Disorder--Treatment-Resistant

betadex has been researched along with Depressive-Disorder--Treatment-Resistant* in 3 studies

Other Studies

3 other study(ies) available for betadex and Depressive-Disorder--Treatment-Resistant

ArticleYear
Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids.
    The American journal of psychiatry, 2021, 03-01, Volume: 178, Issue:3

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depressive Disorder, Treatment-Resistant; Drug Combinations; Humans; Neurosteroids; Pregnanes; Pregnanolone; Pyrazoles

2021
Approval of esketamine for treatment-resistant depression.
    The lancet. Psychiatry, 2020, Volume: 7, Issue:3

    Topics: beta-Cyclodextrins; Depression; Depressive Disorder, Treatment-Resistant; Drug Combinations; Humans; Ketamine; Pregnanolone; United States; United States Food and Drug Administration

2020
US Food and Drug Administration approval of esketamine and brexanolone.
    The lancet. Psychiatry, 2019, Volume: 6, Issue:12

    Topics: Antidepressive Agents; beta-Cyclodextrins; Depression, Postpartum; Depressive Disorder, Treatment-Resistant; Drug Combinations; Female; Humans; Ketamine; Pregnanolone; United States; United States Food and Drug Administration

2019